Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenji Tamura
Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive, Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial
The Lancet Oncology
Oncology
Brain Metastatic Cancer Cells Release microRNA-181c-containing Extracellular Vesicles Capable of Destructing Blood–brain Barrier
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Comprehensive Screening of Target Molecules by Next-Generation Sequencing in Patients With Malignant Solid Tumors: Guiding Entry Into Phase I Clinical Trials
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Black Humic Acid Dynamics During Natural Reforestation of Japanese Pampas Grass (Miscanthus Sinensis)
Soil Biology and Biochemistry
Soil Science
Microbiology
Pathological Chemotherapy Response Score Is Prognostic in Tubo-Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis of Individual Patient Data
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Tumour-Infiltrating Lymphocytes Are Correlated With Higher Expression Levels of PD-1 and PD-L1 in Early Breast Cancer
ESMO Open
Cancer Research
Oncology
Phase 1 Dose-Escalation Study of Single-Agent Veliparib in Japanese Patients With Advanced Solid Tumors
Cancer Science
Cancer Research
Medicine
Oncology
A Double‐blind, Randomized, Multicenter Phase 3 Study of Palonosetron vs Granisetron Combined With Dexamethasone and Fosaprepitant to Prevent Chemotherapy‐induced Nausea and Vomiting in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Safety and Tolerability of AZD5363 in Japanese Patients With Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index
Clinical Breast Cancer
Cancer Research
Oncology
1
2
›